See more : NeutriSci International Inc. (NU.V) Income Statement Analysis – Financial Results
Complete financial analysis of Deva Holding A.S. (DEVA.IS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Deva Holding A.S., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Husqvarna AB (publ) (HUSQF) Income Statement Analysis – Financial Results
- Magazine Luiza S.A. (MGLU3.SA) Income Statement Analysis – Financial Results
- China Gold International Resources Corp. Ltd. (JINFF) Income Statement Analysis – Financial Results
- Oxurion NV (0G99.L) Income Statement Analysis – Financial Results
- Cembre S.p.A. (CMB.MI) Income Statement Analysis – Financial Results
Deva Holding A.S. (DEVA.IS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.deva.com.tr
About Deva Holding A.S.
Deva Holding A.S. manufactures and sells pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, and sensory organs. In addition, the company offers cephalosporins, penicillin, inhalation products, solid and liquid oncology, animal health products, active pharmaceutical ingredients, ampoules, liquid and lyophilized vials, eye drops, medical ampoules for sterile injectable products, and cologne. It also exports its products to approximately 60 countries. The company was incorporated in 1958 and is based in Istanbul, Turkey. Deva Holding A.S. is a subsidiary of Eastpharma S.à R.L.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.33B | 4.48B | 2.33B | 1.86B | 1.37B | 1.04B | 800.30M | 688.46M | 576.38M | 467.94M | 418.39M | 419.51M | 404.97M | 385.66M | 332.64M | 216.99M | 267.26M | 181.92M | 230.28M |
| Cost of Revenue | 6.58B | 2.13B | 971.24M | 898.11M | 688.52M | 543.19M | 470.42M | 425.08M | 353.67M | 314.46M | 268.28M | 251.09M | 268.45M | 244.18M | 204.29M | 155.86M | 118.81M | 86.11M | 110.78M |
| Gross Profit | 4.75B | 2.34B | 1.36B | 965.22M | 685.46M | 497.49M | 329.88M | 263.38M | 222.71M | 153.48M | 150.11M | 168.42M | 136.53M | 141.48M | 128.35M | 61.12M | 148.45M | 95.82M | 119.50M |
| Gross Profit Ratio | 41.89% | 52.34% | 58.32% | 51.80% | 49.89% | 47.80% | 41.22% | 38.26% | 38.64% | 32.80% | 35.88% | 40.15% | 33.71% | 36.68% | 38.58% | 28.17% | 55.55% | 52.67% | 51.89% |
| Research & Development | 1.07B | 163.06M | 73.97M | 80.85M | 39.39M | 35.78M | 28.83M | 11.96M | 13.12M | 4.43M | 3.87M | 2.82M | 6.02M | 3.56M | 1.79M | 4.98M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 254.94M | 121.89M | 49.47M | 47.67M | 27.74M | 30.03M | 17.88M | 17.87M | 13.06M | 7.17M | 7.64M | 28.06M | 31.21M | 33.06M | 45.58M | 41.80M | 2.84M | 4.77M | 0.00 |
| Selling & Marketing | 646.85M | 303.42M | 141.88M | 48.18M | 55.26M | 46.34M | 38.06M | 28.74M | 30.37M | 28.56M | 26.70M | 78.46M | 106.27M | 100.83M | 74.38M | 78.82M | 8.88M | 8.26M | 0.00 |
| SG&A | 901.79M | 425.31M | 191.36M | 95.85M | 83.00M | 76.37M | 55.95M | 46.61M | 43.43M | 35.73M | 34.34M | 106.52M | 137.48M | 133.89M | 119.95M | 120.62M | 11.72M | 13.03M | 0.00 |
| Other Expenses | 762.29M | 551.82K | 1.21M | 724.98K | 488.31K | 1.88M | 0.00 | 0.00 | -1.59M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.74B | 1.09B | 518.02M | 331.88M | 285.58M | 247.77M | 191.76M | 148.70M | 132.77M | 111.36M | 111.78M | 105.74M | 106.20M | 134.65M | 137.46M | 124.31M | 82.56M | 57.63M | -2.59M |
| Cost & Expenses | 9.32B | 3.22B | 1.49B | 1.23B | 974.10M | 790.96M | 662.17M | 573.78M | 486.44M | 425.82M | 380.06M | 356.83M | 374.65M | 378.84M | 341.75M | 280.17M | 201.37M | 143.73M | 108.20M |
| Interest Income | 204.09M | 68.81M | 17.86M | 9.15M | 4.22M | 7.38M | 60.63M | 54.21M | 51.10M | 51.40M | 48.47M | 49.18M | 40.53M | 8.25M | 15.19M | 342.70K | 3.48M | 803.87K | 0.00 |
| Interest Expense | 1.65B | 514.76M | 227.91M | 120.76M | 124.66M | 112.87M | 112.83M | 100.95M | 93.72M | 88.28M | 72.75M | 70.99M | 85.32M | 17.28M | 38.10M | 58.61M | 50.71M | 15.20M | 0.00 |
| Depreciation & Amortization | 679.86M | 86.93M | 79.16M | 59.76M | 46.09M | 34.89M | 30.89M | 27.47M | 26.67M | 25.20M | 24.65M | 22.82M | 18.68M | 17.15M | 16.70M | 11.47M | 10.77M | 10.60M | 10.14M |
| EBITDA | 4.30B | 1.93B | 1.47B | 830.90M | 454.78M | 301.68M | 180.23M | 148.99M | 122.67M | 69.96M | 120.67M | 135.01M | 16.09M | 22.16M | 44.81M | -39.31M | 130.44M | -46.41M | 132.22M |
| EBITDA Ratio | 37.96% | 41.04% | 61.21% | 43.34% | 33.92% | 29.19% | 28.66% | 28.86% | 29.74% | 25.09% | 25.81% | 33.13% | 22.11% | 8.36% | 13.47% | -18.00% | 0.55% | -25.54% | 57.42% |
| Operating Income | 2.01B | 1.69B | 1.35B | 756.52M | 426.69M | 277.24M | 145.33M | 122.04M | 98.40M | 45.16M | 47.43M | 63.64M | 30.33M | 6.82M | 12.91M | -63.19M | 97.47M | -57.01M | 122.08M |
| Operating Income Ratio | 17.74% | 37.76% | 58.07% | 40.60% | 31.05% | 26.64% | 18.16% | 17.73% | 17.07% | 9.65% | 11.34% | 15.17% | 7.49% | 1.77% | 3.88% | -29.12% | 36.47% | -31.34% | 53.02% |
| Total Other Income/Expenses | -33.93M | -391.13M | -194.95M | -109.98M | -119.19M | -95.02M | -44.13M | -50.06M | -46.70M | -40.11M | -23.31M | -22.64M | -7.49M | -9.03M | -22.91M | -45.96M | -259.00 | -340.00 | -100.19M |
| Income Before Tax | 1.98B | 1.30B | 1.16B | 646.54M | 280.69M | 155.97M | 94.58M | 71.98M | 51.70M | 5.05M | 24.12M | 41.21M | -14.46M | -2.20M | -10.00M | -109.15M | 97.47M | -57.01M | 21.89M |
| Income Before Tax Ratio | 17.44% | 29.02% | 49.71% | 34.70% | 20.43% | 14.99% | 11.82% | 10.45% | 8.97% | 1.08% | 5.76% | 9.82% | -3.57% | -0.57% | -3.01% | -50.30% | 36.47% | -31.34% | 9.51% |
| Income Tax Expense | -1.41B | -60.67M | -11.76M | -4.91M | -5.32M | 19.61M | 2.04M | 11.64M | 4.09M | -3.65M | -469.52K | 6.96M | 1.17M | -603.20K | -1.81M | 299.77K | 6.89M | -8.14M | 7.43M |
| Net Income | 3.39B | 1.36B | 1.17B | 651.45M | 286.02M | 136.36M | 92.54M | 60.33M | 47.66M | 8.72M | 24.60M | 34.24M | -15.63M | -1.60M | -8.19M | -91.43M | 90.61M | -48.87M | 14.46M |
| Net Income Ratio | 29.88% | 30.38% | 50.21% | 34.96% | 20.82% | 13.10% | 11.56% | 8.76% | 8.27% | 1.86% | 5.88% | 8.16% | -3.86% | -0.42% | -2.46% | -42.14% | 33.90% | -26.86% | 6.28% |
| EPS | 16.93 | 6.80 | 5.85 | 3.26 | 1.43 | 0.68 | 0.46 | 0.30 | 0.24 | 0.04 | 0.12 | 0.17 | -0.09 | -0.01 | -0.09 | -0.81 | 0.01 | -0.78 | 0.13 |
| EPS Diluted | 16.93 | 6.80 | 5.85 | 3.26 | 1.43 | 0.68 | 0.46 | 0.30 | 0.24 | 0.04 | 0.12 | 0.17 | -0.09 | -0.01 | -0.09 | -0.81 | 0.01 | -0.78 | 0.13 |
| Weighted Avg Shares Out | 199.99M | 199.99M | 199.99M | 199.99M | 199.99M | 199.99M | 200.02M | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M | 180.07M | 156.58M | 90.43M | 113.52M | 65.38M | 62.90M | 113.52M |
| Weighted Avg Shares Out (Dil) | 199.99M | 199.99M | 199.99M | 199.99M | 199.99M | 200.02M | 200.02M | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M | 180.07M | 156.58M | 90.43M | 113.52M | 6.54B | 62.90M | 113.52M |
Source: https://incomestatements.info
Category: Stock Reports